Theratechnologies Inc.
TH.TO
TSX
| 02/28/2025 | 11/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -23.82% | 10.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -23.82% | 10.63% | |||
| Cost of Revenue | -42.86% | 34.84% | |||
| Gross Profit | -17.68% | 4.57% | |||
| SG&A Expenses | 0.35% | 15.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.78% | 46.96% | |||
| Operating Income | 106.20% | -85.21% | |||
| Income Before Tax | 106.16% | -278.89% | |||
| Income Tax Expenses | -69.93% | 35.05% | |||
| Earnings from Continuing Operations | 101.48% | -355.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 101.48% | -355.68% | |||
| EBIT | 106.20% | -85.21% | |||
| EBITDA | 74.13% | -79.96% | |||
| EPS Basic | 101.50% | -355.75% | |||
| Normalized Basic EPS | 185.60% | -125.67% | |||
| EPS Diluted | 101.44% | -366.83% | |||
| Normalized Diluted EPS | 184.00% | -125.67% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 2.10% | -0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||